Bacopa monnieri has been used in Ayurvedic medicine to improve memory and cognition. The active constituent responsible for its pharmacological effects is bacoside A, a mixture of dammarane-type triterpenoid saponins containing sugar chains linked to a steroid aglycone skeleton. Triterpenoid saponins have been reported to be transformed in vivo to metabolites that give better biological activity and pharmacokinetic characteristics. Thus, the activities of the parent compounds (bacosides), aglycones (jujubogenin and pseudojujubogenin) and their derivatives (ebelin lactone and bacogenin A1) were compared using a combination of in silico and in vitro screening methods. The compounds were docked into 5-HT_1A, 5-HT_2A, D₁, D₂, M₁ receptors and acetylcholinesterase (AChE) using AutoDock and their central nervous system (CNS) drug-like properties were determined using Discovery Studio molecular properties and ADMET descriptors. The compounds were screened in vitro using radioligand receptor binding and AChE inhibition assays. In silico studies showed that the parent bacosides were not able to dock into the chosen CNS targets and had poor molecular properties as a CNS drug. In contrast, the aglycones and their derivatives showed better binding affinity and good CNS drug-like properties, were well absorbed through the intestines and had good blood brain barrier (BBB) penetration. Among the compounds tested in vitro, ebelin lactone showed binding affinity towards M₁ (K_i = 0.45 μM) and 5-HT_2A (4.21 μM) receptors. Bacoside A and bacopaside X (9.06 μM) showed binding affinity towards the D₁ receptor. None of the compounds showed any inhibitory activity against AChE. Since the stimulation of M₁ and 5-HT_2A receptors has been implicated in memory and cognition and ebelin lactone was shown to have the strongest binding energy, highest BBB penetration and binding affinity towards M₁ and 5-HT_2A receptors, we suggest that B. monnieri constituents may be transformed in vivo to the active form before exerting their pharmacological activity.

The allylsilanes, (R)-E- and (R)-Z-4-trimethylsilylpent-2-ene 16, were prepared in essentially an enantiomerically and geometrically pure state (er >99.95 : 0.05, E : Z and Z : E >99.95 : 0.05) by, successively, conjugate addition of lithium dimethylcuprate to N-[(E)-3′-trimethylsilylpropenoyl]-(7S)-10,10-dimethyl-4-aza-5-thiatricyclo[5.2.1.0^3,7]decane 5,5-dioxide, to give N-[(E)-(3′R)-3′-trimethylsilylbutanoyl]-(7S)-10,10-dimethyl-4-aza-5-thiatricyclo[5.2.1.0^3,7]decane 5,5-dioxide 13, removal of the chiral auxiliary with bromomagnesium benzyloxide, aldol reaction with acetaldehyde, and decarboxylative elimination, to give either the Z- or E-isomer. Both the E- and Z-allylsilanes 16 reacted with the adamantyl cation to give mixtures of E- and Z-4-adamantylpent-2-enes 17. The E-allylsilane gave the E- and Z-products in a ratio of 40 : 60, and the Z-allylsilane gave the E- and Z-products in a ratio of 99.8 : 0.02. The enantiomer ratio was >99 : 1 for the reaction of the E-allylsilane giving the Z-product, 90 : 10 for the E-allylsilane giving the E-product, and 95 : 5 for the Z-allylsilane giving the E-product, showing that the reactions were stereospecific to a high degree, but not always quite completely so. The allenylsilane, 2-trimethylsilylpenta-2,3-diene 29, was prepared enantiomerically highly enriched (er 99 : 1) by copper-catalysed reaction of methylmagnesium chloride with (S)-4-trimethylsilylbut-3-yn-2-yl camphor-10-sulfonate 28. The allenylsilane 29 reacted with the adamantyl cation to give (S)-4-adamantylpent-2-yne (S)-30 with the same level of enantiomeric purity, showing that the reaction was, as accurately as can be measured, completely stereospecific. The allenylsilane 29 also reacted with isobutanal in the presence of titanium tetrachloride to give 2,4-dimethylhept-5-yn-3-ol as a mixture of diastereoisomers, syn31 and anti32, in a ratio of 95 : 5, with the major diastereoisomer present as a mixture of enantiomers (4R,5R) : (4S,5S) in a ratio of 99 : 1, showing that the reaction was, as accurately as can be measured, completely stereospecific in the anti sense. The corresponding propargylsilane, 4-trimethylsilylpent-2-yne 37, reacted with the adamantyl cation to give dienes assigned the structures 2,3-diadamantyl-1,3-pentadiene 42 and 2,4-diadamantyl-1,3-pentadiene 43, and reacted with isobutanal in the presence of titanium tetrachloride to give 2-(1-hydroxy-2-methylpropyl)-3-trimethylsilylpenta-1,3-dienes 45 and 2,4-dimethyl-5-trimethylsilylhept-5-en-3-one 46. The enantiomerically enriched propargylsilane (R)-1,3-bis(trimethylsilyl)but-1-yne 62 (er >99.7 : 0.3) was prepared from the sultam 13, by removal of the chiral auxiliary with lithium ethoxide, reduction of the ethyl ester to give (R)-3-trimethylsilylbutanal 60, enol triflate formation, β-elimination and C-silylation. The propargylsilane 62 reacted with 2,4-dinitrobenzaldehyde in the presence of titanium tetrachloride to give the allenes, 1-(2,4-dinitrophenyl)-2-trimethylsilylpenta-2,3-dienols 63–66, as two diastereoisomers in a ratio of 2 : 1, each of which was a pair of enantiomers in a ratio of approximately 3 : 1, showing that there was considerable loss of stereospecificity, but that what there was was in the anti sense. A similar reaction with isobutanal gave a similar set of four allenes, 2-methyl-4-trimethylsilylhepta-4,5-dien-3-ol 73–76, but with a negligible degree of stereospecificity.

Background: Boesenbergia rotunda(Roxb.) Schlecht (family zingiberaceae) is a rhizomatous herb that is distributed from north-eastern India to south-east Asia, especially in Indonesia, Thailand and Malaysia. Previous research has shown that the crude extract of this plant has cytotoxic properties. The current study examines the cytotoxic properties of boesenbergin A isolated fromBoesenbergia rotunda.Methods: MTT assay was used to check the cytotoxicity of boesenbergin A. The morphological assessment of apoptosis was monitored using normal and fluorescence microscopy. The early and late phase of apoptosis was investigated using annexin V and DNA laddering assays, respectively. The mitochondrial membrane potential (MMP) was assessed by fluorescence microscopy. Human apoptosis proteome profiler assays were performed to investigate the mechanism of cell death. In addition, the protein levels of Bax, Bcl2 and HSP 70 were also analyzed using western blot. Assays of caspase =-3/7, -8 and =-9 were carried out in order to test for induction during treatment. Lastly, cell cycle progression was analyzed using flow cytometry.Results: Boesenbergin A was found to have the highest toxicity towards CEMss cancer cells (IC₅₀ = 8 μg/ml). The morphology of CEMss cells after treatment showed evidence of apoptosis that included blebbing and chromatin condensation. The annexin V assay revealed that early apoptosis is induced after treatment. The DNA laddering assay confirmed that DNA fragmentation had occurred during late apoptosis. The cell cycle analysis indicated that boesenbergin A was able to induce G2/M phase arrest in CEMss cells. The activity of caspases -3/7, -8 and -9 was increased after treatment which indicates both intrinsic and extrinsic pathways are induced during apoptosis. The involvement of mitochondria was established by increased mitochondrial membrane potential and up and down regulation of Bcl2 and Bax proteins as well as HSP70.Conclusion: In conclusion, the results demonstrated that boesenbergin A induced apoptosis of CEMss cells through Bcl2/Bax signaling pathways with the involvement of caspases and G2/M phase cell cycle arrest. The current findings warrant further research on boesenbergin A as a novel chemotherapeutic agent for leukemia intervention including studies in animal models.